Booking an appointment is easy and we take time to really understand you, not just what the chart says
The Medicines and Healthcare products Regulatory Agency (MHRA) has approved the UK's first GLP-1 receptor agonist tablet for weight loss and weight management, marking a significant development in the country's obesity market
Market positioning: Semaglutide is becoming more affordable with generics, whereas tirzepatide (by Eli Lilly) remains a premium, patented therapy
Everyones dietary needs and preferences are unique, so its always a good idea to consult a healthcare professional or registered dietitian about a specific meal plan
Whatever your reason, considering semaglutide as part of your journey might be a game-changer
Trachootham, D., Alexandre, J., & Huang, P